Aurinia Pharmaceuticals to Present at the 2016 Rodman & Renshaw 18th Annual Global Investment Conference

VICTORIA, British Columbia-- Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH / TSX:AUP) today announced that its Chief Operating Officer, Michael R. Martin, will present a corporate overview of the Company at the 2016 Rodman & Renshaw 18th Annual Global Investment Conference, taking place September 11th-13th at the Lotte New York Palace Hotel in New York City. The presentation will also be available via webcast at the link listed below.

Aurinia Presentation Details



Monday, September 12th, 2016


10:00 a.m. Eastern time


Lotte New York Palace Hotel, Louis Room (4th floor)


About Aurinia
Aurinia is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need. The company is headquartered in Victoria, BC and focuses its development efforts globally.

Visit for more information.

Investor & Media Contact:
Celia Economides
Associate VP, Investor Relations

Source: Aurinia Pharmaceuticals Inc.